KR20210141511A - 신규 선택 마커-포함 세포주 및 단백질 생산을 위한 그의 용도 - Google Patents

신규 선택 마커-포함 세포주 및 단백질 생산을 위한 그의 용도 Download PDF

Info

Publication number
KR20210141511A
KR20210141511A KR1020217029997A KR20217029997A KR20210141511A KR 20210141511 A KR20210141511 A KR 20210141511A KR 1020217029997 A KR1020217029997 A KR 1020217029997A KR 20217029997 A KR20217029997 A KR 20217029997A KR 20210141511 A KR20210141511 A KR 20210141511A
Authority
KR
South Korea
Prior art keywords
dhodh
cell line
gene
sequence
leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020217029997A
Other languages
English (en)
Korean (ko)
Inventor
브루노 루이즈 두마스
모하메드 내빌 루니스
Original Assignee
사노피
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 사노피 filed Critical 사노피
Publication of KR20210141511A publication Critical patent/KR20210141511A/ko
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/001—Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y103/00—Oxidoreductases acting on the CH-CH group of donors (1.3)
    • C12Y103/05—Oxidoreductases acting on the CH-CH group of donors (1.3) with a quinone or related compound as acceptor (1.3.5)
    • C12Y103/05002—Dihydroorotate dehydrogenase (1.3.5.2)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
KR1020217029997A 2019-03-19 2020-03-19 신규 선택 마커-포함 세포주 및 단백질 생산을 위한 그의 용도 Pending KR20210141511A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19305331.1 2019-03-19
EP19305331 2019-03-19
PCT/EP2020/057583 WO2020188021A1 (en) 2019-03-19 2020-03-19 Novel selection marker-comprising cell line and uses thereof for protein production

Publications (1)

Publication Number Publication Date
KR20210141511A true KR20210141511A (ko) 2021-11-23

Family

ID=66001151

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020217029997A Pending KR20210141511A (ko) 2019-03-19 2020-03-19 신규 선택 마커-포함 세포주 및 단백질 생산을 위한 그의 용도

Country Status (14)

Country Link
US (1) US12529071B2 (https=)
EP (1) EP3942054A1 (https=)
JP (1) JP7609795B2 (https=)
KR (1) KR20210141511A (https=)
CN (1) CN113811615B (https=)
AU (1) AU2020242966B2 (https=)
BR (1) BR112021018124A2 (https=)
CA (1) CA3134116A1 (https=)
IL (1) IL286419A (https=)
MX (1) MX2021011303A (https=)
SG (1) SG11202110105UA (https=)
TW (1) TWI881970B (https=)
WO (1) WO2020188021A1 (https=)
ZA (1) ZA202106718B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI912369B (zh) * 2020-09-21 2026-01-21 法商賽諾菲公司 用於生產治療蛋白之高生產重組中國倉鼠卵巢細胞株之世代

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8717430D0 (en) 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product
KR100267720B1 (ko) 1997-12-29 2001-03-02 박호군 사람 글루타민 합성효소 유전자를 포함하는 발현벡터 및 이를 이용하여 동물세포에서 에리트로포이에틴을 고수율로 생산하는 방법
US20030166201A1 (en) * 2001-04-30 2003-09-04 Jensen Michael C. Selection systems for genetically modified cells
AU2007250735A1 (en) * 2006-05-16 2007-11-22 Daiichi Sankyo Company, Limited Method for high-level secretory production of protein
US9234210B2 (en) 2010-08-25 2016-01-12 Intrexon Ceu, Inc. Selectable markers and related methods
RU2556816C1 (ru) 2014-03-12 2015-07-20 Открытое акционерное общество "Фармацевтический импорт, экспорт" (ОАО "Фармимэкс") Штамм клеток яичников китайского хомячка - продуцент рекомбинантного антитела против фактора некроза опухоли альфа человека
AU2015334872B2 (en) 2014-10-23 2021-12-16 Sanofi Novel selection marker for cell transfection and protein production
US11096934B2 (en) 2015-09-01 2021-08-24 The Broad Institute, Inc. Compounds and methods useful for treating or preventing hematological cancers
US10736911B2 (en) * 2015-12-29 2020-08-11 The Board Of Trustees Of The Leland Stanford Junior University Use of a DHODH inhibitor in combination with an inhibitor of pyrimidine salvage
CN109777837A (zh) 2018-12-26 2019-05-21 首都医科大学 一种利用CRISPR/Cas9系统构建致死基因全身性敲除小鼠模型的方法
TWI912369B (zh) 2020-09-21 2026-01-21 法商賽諾菲公司 用於生產治療蛋白之高生產重組中國倉鼠卵巢細胞株之世代

Also Published As

Publication number Publication date
AU2020242966A1 (en) 2021-10-21
CN113811615B (zh) 2025-11-11
TW202102669A (zh) 2021-01-16
JP7609795B2 (ja) 2025-01-07
CA3134116A1 (en) 2020-09-24
TWI881970B (zh) 2025-05-01
ZA202106718B (en) 2023-04-26
EP3942054A1 (en) 2022-01-26
MX2021011303A (es) 2021-10-22
US12529071B2 (en) 2026-01-20
AU2020242966B2 (en) 2025-09-25
BR112021018124A2 (pt) 2021-11-16
CN113811615A (zh) 2021-12-17
IL286419A (en) 2021-10-31
WO2020188021A1 (en) 2020-09-24
US20220177909A1 (en) 2022-06-09
SG11202110105UA (en) 2021-10-28
JP2022526497A (ja) 2022-05-25

Similar Documents

Publication Publication Date Title
JP5432117B2 (ja) 宿主細胞中の組換えタンパク質の発現を増進するための組換え発現ベクター要素（ｒＥＶＥ）
Yang et al. Control of gene conversion and somatic hypermutation by immunoglobulin promoter and enhancer sequences
US12203103B2 (en) Selection marker for cell transfection and protein production
US20220089775A1 (en) Multiply auxotrophic cell line for the production of recombinant proteins and methods thereof
IL295090A (en) Safe harbor loci
CN113811615B (zh) 包含选择标记物的新型细胞系及其用于蛋白质生产的用途
EP4214308B1 (en) Generation of a high producing recombinant chinese hamster ovary cell line for therapeutic protein production
RU2820830C2 (ru) Линия клеток, содержащая новый маркер отбора, и ее применение для продуцирования белков
RU2849601C1 (ru) Получение рекомбинантной линии клеток китайского хомячка, характеризующейся высоким продуцированием, для продуцирования терапевтических белков
HK40096091A (en) Generation of a high producing recombinant chinese hamster ovary cell line for therapeutic protein production
HK40096091B (en) Generation of a high producing recombinant chinese hamster ovary cell line for therapeutic protein production

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

D21 Rejection of application intended

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D21-EXM-PE0902 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

D22 Grant of ip right intended

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D22-EXM-PE0701 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701